MedTrace Logo

Leuven Tolerogenic Protocol for Intestinal Transplantation

NCT02314949 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2024-07-15

No results posted yet for this study

Summary

An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells.

This protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.

Conditions

  • Organ Transplantation
  • Intestine

Interventions

PROCEDURE

intestinal transplantation

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02314949 on ClinicalTrials.gov